Community/Retail

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, gives counseling points that pharmacists should provide to diabetic patients.

Chris Hatwig, MS, FASHP of Apexus discusses what health-system pharmacists need to know about the potential for HRSA audits to review 340B program compliance requirements.

Abbott has announced that it has completed its acquisition of Tendyne Holdings, a private medical device company focused on developing minimally invasive mitral valve replacement therapies.

The Process Behind Innovation

By

Over the past few months, I have described generalities associated with the concept of innovation by defining the terms, maintaining that this movement has staying power, and providing perspectives on how pharmacy remains opposed to it.

Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.